India to United States: Leflunomide Export Trade Route
India has recorded 119 verified shipments of Leflunomide exported to United States, representing a combined trade value of $5.3M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $44.7K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED, which accounts for 70% of total export value with 65 shipments worth $3.7M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $4.5M USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, LUPIN LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Leflunomide corridor is one of India's established pharmaceutical export routes, with 119 shipments documented worth a combined $5.3M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's leflunomide manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $44.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with leflunomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 20.4%, placing it at rank #9 among India's top leflunomide export destinations globally.
On the import side, key buyers of Indian leflunomide in United States include EVERSANA LIFE SCIENCE SERVICES, XXPINXXHARXXCEUXXCALXXINCX, LUPIN PHARMACEUTICALS INC and 9 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 77 shipments valued at $4.5M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#9
- Annual growth+20.4%
- Demand growth+19.2%
- Regulatory ease76/100
Top 10 Indian Leflunomide Exporters to United States
Showing top 10 of 8 Indian suppliers exporting Leflunomide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED Avg $57.2K per shipment | 65 | $3.7M | 70.0% |
| 2 | CADILA HEALTHCARE LIMITED Avg $70.0K per shipment | 10 | $699.9K | 13.2% |
| 3 | LUPIN LIMITED Avg $33.9K per shipment | 11 | $372.8K | 7.0% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED Avg $11.5K per shipment | 25 | $288.7K | 5.4% |
| 5 | APL HEALTHCARE LIMITED Avg $36.8K per shipment | 4 | $147.2K | 2.8% |
| 6 | CADILA HEALTHCARE LTD Avg $44.0K per shipment | 2 | $88.0K | 1.7% |
| 7 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $47 per shipment | 1 | $47 | 0.0% |
| 8 | EMCURE PHARMACEUTICALS LIMITED Avg $10 per shipment | 1 | $10 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting leflunomide to United States, ranked by total trade value. The listed exporters are: ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, LUPIN LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, APL HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, GLOBYZ BIOPHARMA PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED. ZYDUS LIFESCIENCES LIMITED is the dominant supplier with 65 shipments worth $3.7M USD, giving it a 70% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Leflunomide Importers in United States
Showing top 10 of 12 known buyers in United States receiving Leflunomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian leflunomide in United States include EVERSANA LIFE SCIENCE SERVICES, XXPINXXHARXXCEUXXCALXXINCX, LUPIN PHARMACEUTICALS INC, AUROBINDO PHARMA USA INC, J. KNIPPER & COMPANY, among 12 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $4.5M USD across 77 shipments — representing 85% of all leflunomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 77 | $4.5M | 84.8% |
| 2 | XXPINXXHARXXCEUXXCALXXINCX | 5 | $173.5K | 3.3% |
| 3 | LUPIN PHARMACEUTICALS INC | 5 | $173.1K | 3.3% |
| 4 | AUROBINDO PHARMA USA INC | 2 | $117.9K | 2.2% |
| 5 | J. KNIPPER & COMPANY | 13 | $114.6K | 2.2% |
| 6 | J KNIPPER COMPANY | 7 | $91.4K | 1.7% |
| 7 | J. KNIPPER & COMPANY, | 2 | $77.8K | 1.5% |
| 8 | XXROBXXDO XXARMXXUSAXX INXX | 2 | $29.2K | 0.5% |
| 9 | Lupin Pharmaceutical Inc | 1 | $26.3K | 0.5% |
| 10 | J.KNIPPER & COMPANY | 3 | $4.9K | 0.1% |
Showing top 10 of 12 Leflunomide importers in United States on this route.
Top 10 Leflunomide Formulations Imported by United States
Showing top 10 of 62 product formulations shipped on the India to United States Leflunomide route, ranked by trade value
United States imports a wide range of leflunomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEFLUNOMIDE TABS USP 20MG 1X30 BNO;Z305781(30744 PACKS) — accounts for $1.4M USD across 1 shipments. There are 62 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEFLUNOMIDE TABS USP 20MG 1X30 BNO;Z305781(30744 PACKS) | 1 | $1.4M | 26.6% |
| 2 | LEFLUNOMIDE TAB 20MG X 30'S US | 8 | $291.6K | 5.5% |
| 3 | LEFLUNOMIDE TABS USP 20 MG - 1 X 30, B.No Z500960 TO Z500964 MFG.DT. 02/2025 EXP.DT. 01/2027 | 1 | $216.0K | 4.1% |
| 4 | PHARMACEUTICAL MEDICINE FOR HUMAN USE LEFLUNOMIDE TABS USP 20 MG 1 x 30 | 3 | $206.5K | 3.9% |
| 5 | LEFLUNOMIDE TABLETS USP 20MG [62640 PACK | 2 | $202.0K | 3.8% |
| 6 | LEFLUNOMIDE TABLETS USP 20MG [60576 PACKX1X30 = 1817280 NOS] BATCH NO. Z304635& Z304636 MANUFACTURING . DT. 09/2023 EXP.DT. 08/20 | 2 | $181.3K | 3.4% |
| 7 | PHARMA MEDICINE FOR HUMAN USE-LEFLUNOMIDE TABS USP 20 MG - 1 X 30-QTY-61,680.000 PAC-AS PER INVNOS | 6 | $174.9K | 3.3% |
| 8 | PHARMA MEDICINE FOR HUMAN USE-LEFLUNOMIDE TABS USP 20 MG - 1 X 30-QTY-91,920.000-PAC | 3 | $131.7K | 2.5% |
| 9 | LEFLUNOMIDE TABS USP 20MG 1X30 BNO;Z500202,Z500203,Z500204(92640 PACKS) | 1 | $125.2K | 2.4% |
| 10 | PHARMA MEDICINE FOR HUMAN USE LEFLUNOMIDE TABLET USP 20 MG 1 X 30 Qty 82152 00PAC AS PER INV | 1 | $112.2K | 2.1% |
Showing top 10 of 62 Leflunomide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 57 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's leflunomide exports to United States are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 65 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, LUPIN LIMITED — together account for 90% of total trade value on this route. The average shipment value of $44.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as leflunomide tab 20mg x 30's us and leflunomide tabs usp 20 mg - 1 x 30, b.no z500960 to z500964 mfg.dt. 02/2025 exp.dt. 01/2027, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 77 shipments worth $4.5M USD — representing 85% of all leflunomide imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.3M
- Avg. Shipment
- $44.7K
- Suppliers
- 8
- Buyers
- 12
- Transit (Sea)
- ~24 days
- Annual Growth
- +20.4%
Related Analysis
Reverse Direction
United States → India — Leflunomide (Import)Other Leflunomide Routes
Unlock the Full India to United States Leflunomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 119 shipments on this route.
Frequently Asked Questions — India to United States Leflunomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Leflunomide to United States?
The leading Indian exporters of Leflunomide to United States are ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, LUPIN LIMITED. ZYDUS LIFESCIENCES LIMITED holds the largest market share at approximately 70% of total trade value on this route.
Q What is the total value of Leflunomide exports from India to United States?
India exports Leflunomide to United States worth approximately $5.3M USD across 119 recorded shipments. The average value per shipment is $44.7K USD.
Q Which ports does India use to ship Leflunomide to United States?
The most active port of origin is MUNDRA SEA with 57 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to United States for Leflunomide?
The average transit time for Leflunomide shipments from India to United States is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Leflunomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.4% with demand growth tracking at 19.2%. The route is ranked #9 among India's top Leflunomide export destinations globally.
Q How many suppliers are active on the India to United States Leflunomide route?
There are currently 8 active Indian suppliers exporting Leflunomide to United States. The market is moderately concentrated with ZYDUS LIFESCIENCES LIMITED accounting for 70% of total shipment value.
Q Who are the main importers of Leflunomide from India in United States?
The leading importers of Indian Leflunomide in United States include EVERSANA LIFE SCIENCE SERVICES, XXPINXXHARXXCEUXXCALXXINCX, LUPIN PHARMACEUTICALS INC, AUROBINDO PHARMA USA INC, J. KNIPPER & COMPANY. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 77 shipments worth $4.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Leflunomide.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 12 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 119 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
119 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists